These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19430986)

  • 41. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
    Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
    Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].
    Luo DL; Liu YH; Zhuang HG; Li L; Xu FP; Zhang F; Luo XL; Xu J
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):235-9. PubMed ID: 21615996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: Is It Different between Over and Under 50 Years of Age?
    Monabati A; Vahedi A; Safaei A; Noori S; Mokhtari M; Vahedi L; Zamani M
    Asian Pac J Cancer Prev; 2016; 17(4):2285-9. PubMed ID: 27221931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
    Li C; Romero-Masters JC; Huebner S; Ohashi M; Hayes M; Bristol JA; Nelson SE; Eichelberg MR; Van Sciver N; Ranheim EA; Scott RS; Johannsen EC; Kenney SC
    PLoS Pathog; 2020 Jun; 16(6):e1008590. PubMed ID: 32542010
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?
    Ok CY; Ye Q; Li L; Manyam GC; Deng L; Goswami RR; Wang X; Montes-Moreno S; Visco C; Tzankov A; Dybkaer K; Zhang L; Abramson J; Sohani AR; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Zhang S; Parsons BM; Xu M; Møller MB; Winter JN; Piris MA; Xu-Monette ZY; Medeiros LJ; Young KH
    Oncotarget; 2015 Jun; 6(16):13933-45. PubMed ID: 26101854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The t(9;14)(p13;q32) is a recurrent but rare abnormality in splenic marginal zone lymphoma.
    Kelly RJ; O'connor SJ; Barrans SL; Johnson RJ; Owen RG
    Leuk Lymphoma; 2007 Aug; 48(8):1636-7. PubMed ID: 17701598
    [No Abstract]   [Full Text] [Related]  

  • 47. Primary central nervous system Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a clinicopathologic study of five cases.
    Jamal SE; Li S; Bajaj R; Wang Z; Kenyon L; Glass J; Pang CS; Bhagavathi S; Peiper SC; Gong JZ
    Brain Tumor Pathol; 2014 Oct; 31(4):265-73. PubMed ID: 24399201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
    Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic and immunohistochemical characterization of Epstein-Barr virus-associated diffuse large B-cell lymphoma.
    Al-Humood S; Alqallaf A; Al-Shemmari S; Al-Faris L; Al-Ayadhy B
    Acta Haematol; 2014; 131(1):1-10. PubMed ID: 24008861
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD20-negative CD138-positive leukemic large cell lymphoma with plasmablastic differentiation with an IgH/MYC translocation in an HIV-positive patient.
    Yotsumoto M; Ichikawa N; Ueno M; Higuchi Y; Asano N; Kobayashi H
    Intern Med; 2009; 48(7):559-62. PubMed ID: 19336959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epstein-Barr virus-associated high-grade B-cell lymphoma of mucosal-associated lymphoid tissue in a 9-year-old Boy.
    Tao J; Kahn L
    Arch Pathol Lab Med; 2000 Oct; 124(10):1520-4. PubMed ID: 11035588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Significance of
    Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
    Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
    [No Abstract]   [Full Text] [Related]  

  • 53. Expression of co-inhibitory molecules B7-H4 and B7-H1 in Epstein-Barr virus positive diffuse large B-cell lymphoma and their roles in tumor invasion.
    Jiang Y; Lin J; Zhang J; Lu S; Wang C; Tong Y
    Pathol Res Pract; 2019 Dec; 215(12):152684. PubMed ID: 31679792
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Colorectal diffuse large B-cell lymphoma: molecular subclassification and prognostic significance of immunoglobulin gene translocation.
    Hori Y; Yamamoto H; Nozaki Y; Torisu T; Fujiwara M; Taguchi K; Nishiyama K; Nakamura S; Kitazono T; Oda Y
    Hum Pathol; 2020 Feb; 96():67-78. PubMed ID: 31734190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel five-way translocation, t(3;9;13;8;14)(q27;p13;q32;q24;q32), with concurrent MYC and BCL6 rearrangements in a primary bone marrow B-cell lymphoma.
    Yamamoto K; Matsuoka H; Yakushijin K; Funakoshi Y; Okamura A; Hayashi Y; Minami H
    Cancer Genet; 2011 Sep; 204(9):501-6. PubMed ID: 22018272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases.
    Al-Kawaaz M; Mathew S; Liu Y; Gomez ML; Chaviano F; Knowles DM; Orazi A; Tam W
    Am J Clin Pathol; 2015 Feb; 143(2):288-99. PubMed ID: 25596256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epstein-Barr virus positive diffuse large B-cell lymphoma of the elderly.
    Wong HH; Wang J
    Leuk Lymphoma; 2009 Mar; 50(3):335-40. PubMed ID: 19255922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells.
    Ohashi A; Kato S; Okamoto A; Inaguma Y; Satou A; Tsuzuki T; Emi N; Okamoto M; Nakamura S
    Histopathology; 2017 Jul; 71(1):89-97. PubMed ID: 28231401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and characterization of anaplastic large cell lymphoma and its association with Epstein-Barr virus in Pakistani patients.
    Noorali S; Pervez S; Yaqoob N; Moatter T; Nasir MI; Haroon S; Hodges E; Smith JL
    Pathol Res Pract; 2004; 200(10):669-79. PubMed ID: 15648604
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of the PAX5/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
    Hamada T; Yonetani N; Ueda C; Maesako Y; Akasaka H; Akasaka T; Ohno H; Kawakami K; Amakawa R; Okuma M
    Br J Haematol; 1998 Aug; 102(3):691-700. PubMed ID: 9722295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.